Winston-Salem, NC, United States of America

Dawen Zhao

This inventor holds 1 USPTO granted patent. Top assignee: Wake Forest University. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dawen Zhao. Retrieved from https://idiyas.com/inventor/dawen-zhao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dawen Zhao: Inventor in Immunotherapeutic Nanoparticles.

Introduction

Dawen Zhao is an inventor associated with Wake Forest University in Winston-Salem, North Carolina. His patent work focuses on nanoparticle-based approaches for delivering therapeutic agents and supporting antitumor immune responses. Zhao is credited with 1 patent.

Latest Patents

Zhao’s patent, “Immunotherapeutic Nanoparticles and Methods Relating Thereto,” describes compositions containing lipid nanoparticles and nucleic acid therapeutic agents. One example combines calcium phosphate nanoparticles containing a cyclic dinucleotide with a lipid coating that includes phosphatidylserine.

The disclosed compositions may be formulated for delivery to the lungs by inhalation or administered by injection. The patent also describes methods for treating lung cancer and other cancers. Its approach aims to deliver therapeutic agents, including cyclic dinucleotides, to antigen-presenting immune cells and thereby elicit beneficial antitumor immunity.

Career Highlights

Zhao’s listed invention connects nanotechnology with cancer immunotherapy. The patent outlines potential delivery routes and therapeutic applications, including treatment of lung cancer and other cancers. His work is associated with Wake Forest University.

Collaborations

Yang Liu and Neil William Crowe are identified as Zhao’s coworkers.

Conclusion

Dawen Zhao’s patent describes a nanoparticle-based strategy for delivering immune-stimulating agents, with potential applications in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…